Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
143 hedge funds and large institutions have $111M invested in Vaxart in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 57 increasing their positions, 36 reducing their positions, and 17 closing their positions.
204% more call options, than puts
Call options by funds: $2.59M | Put options by funds: $852K
58% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 36
4.99% more ownership
Funds ownership: 35.15% → 40.15% (+5%)
2% less funds holding
Funds holding: 146 → 143 (-3)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
29% less capital invested
Capital invested by funds: $156M → $111M (-$44.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$4.82M |
| 2 |
Goldman Sachs
New York
|
+$2.69M |
| 3 |
Two Sigma Investments
New York
|
+$2.6M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.43M |
| 5 |
Barclays
London,
United Kingdom
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.93M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.62M |
| 3 |
LPL Financial
San Diego,
California
|
-$481K |
| 4 |
SG Americas Securities
New York
|
-$328K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$304K |
VXRT Hedge Fund Activity: Q3 2022 in Review
143 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q3 2022, worth a combined $111M — down 29% from $156M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of VXRT and 14 opened new positions — a net loss of 3 holders — while 36 trimmed existing stakes and 57 added.
The largest buyer was State Street, adding an estimated $4.82M. The largest seller was Morgan Stanley, cutting an estimated $1.93M.
- 143 institutional investors held Vaxart (VXRT) as of Q3 2022, down from 146 in Q2 2022.
- Funds reported $111M of Vaxart stock for Q3 2022, down 29% quarter-over-quarter.
- 14 funds opened new Vaxart positions in Q3 2022 and 17 closed out, a net change of -3 holders.
- The largest Vaxart buyer in Q3 2022 was State Street, an estimated $4.82M added.
- The largest Vaxart seller in Q3 2022 was Morgan Stanley, an estimated $1.93M sold.
Based on aggregated 13F filings for Q3 2022.